| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ars Pharmaceuticals, Inc. (SPRY) has 17 insiders with recent SEC Form 4 filings, including 7 buys and 17 sells. SPRY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.89M | $50.80M | - | |
| Dir | 4.47M | $46.51M | - | |
| Other | 240.0K | $2.49M | - | |
| Other | 240.0K | $2.49M | - | |
| CEO | 240.0K | $2.49M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2024 | Tanimoto Sarina54 | Chief Medical Officer | Sell | 99,478 | $9.02 | $897,368.26 | -0.9% | -0.4% | +13.1% | |
| Feb 28, 2024 | Lowenthal Richard E54 | President And CEO | Sell | 99,478 | $9.02 | $897,368.26 | -0.9% | -0.4% | +13.1% | |
| Sep 29, 2023 | Fitzpatrick Alexander A81 | Chief Legal Officer | Buy | 86,258 | $3.71 | $319,954.01 | +187.8% | +48.9% | +278.8% | |
| Sep 21, 2023 | Ra Capital Management, L.P.53 | Director | Buy | 2,700,000 | $3.03 | $8,183,525.74 | +19.0% | +37.3% | +302.5% | |
| Sep 1, 2023 | Shawver Laura56 | Director | Sale+OE | 100,000 | $7.71 | $770,520.00 | -32.2% | -32.1% | +82.6% | |
| Aug 29, 2023 | Thompson Peter A.65 | Director | Buy | 500,000 | $6.20 | $3,100,000.00 | +6.6% | -34.0% | +93.8% | |
| Aug 29, 2023 | Orbimed Advisors LLC67 | Director | Buy | 500,000 | $6.20 | $3,100,000.00 | +6.6% | -34.0% | +93.8% | |
| Aug 29, 2023 | Ra Capital Management, L.P.53 | Director | Buy | 3,750,000 | $6.20 | $23,250,000.00 | +178.0% | -34.0% | +93.8% | |
| Aug 4, 2023 | Shawver Laura56 | Director | Sale+OE | 45,004 | $7.03 | $316,489.30 | -9.7% | -48.1% | +40.8% | |
| Aug 2, 2023 | Shawver Laura56 | Director | Sale+OE | 54,996 | $7.12 | $391,840.76 | -11.6% | -49.3% | +49.1% |